Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults (clinicaltrials.gov) - Mar 22, 2023 - P3 | N=1831 | Active, not recruiting | Sponsor: Clover Biopharmaceuticals AUS Pty Ltd | Recruiting ➔ Active, not recruiting | Trial completion date: Oct 2023 ➔ Feb 2024 | Trial primary completion date: Mar 2023 ➔ Jun 2023
Enrollment closed • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
|